Healthcare provider profile · identity verified

William M Yates, M.D.

General Practice · BAMBERG, SC · NPI 1740361906

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lovastatin	Lovastatin	522	118
Amlodipine Besylate	Amlodipine Besylate	323	87
Levothyroxine Sodium	Levothyroxine Sodium	266	53
Valsartan	Valsartan	262	49
Potassium Chloride	Potassium Chloride	225	66
Hydrochlorothiazide	Hydrochlorothiazide	223	54
Atorvastatin Calcium	Atorvastatin Calcium	221	62
Alprazolam	Alprazolam	214	35
Metoprolol Succinate	Metoprolol Succinate	183	38
Losartan Potassium	Losartan Potassium	158	41
Gabapentin	Gabapentin	154	33
Celecoxib	Celecoxib	152	31
Esomeprazole Magnesium	Esomeprazole Magnesium	149	37
Omeprazole	Omeprazole	147	34
Montelukast Sodium	Montelukast Sodium	138	26
Furosemide	Furosemide	134	44
Metformin Hcl	Metformin Hcl	125	34
Carvedilol	Carvedilol	123	32
Lisinopril	Lisinopril	108	29
Eliquis	Apixaban	105	20
Vitamin D2	Ergocalciferol (Vitamin D2)	102	26
Trazodone Hcl	Trazodone Hcl	100	20
Albuterol Sulfate Hfa	Albuterol Sulfate	98	30
Ezetimibe	Ezetimibe	97	30
Fenofibrate	Fenofibrate Nanocrystallized	96	26
Ozempic	Semaglutide	91	25
Clonidine Hcl	Clonidine Hcl	88	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	29
Lorazepam	Lorazepam	86	suppressed
Tramadol Hcl	Tramadol Hcl	86	33
Fluticasone Propionate	Fluticasone Propionate	80	26
Tamsulosin Hcl	Tamsulosin Hcl	79	18
Zolpidem Tartrate	Zolpidem Tartrate	79	17
Meloxicam	Meloxicam	76	21
Myrbetriq	Mirabegron	76	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	14
Levetiracetam	Levetiracetam	69	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	67	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	18
Alendronate Sodium	Alendronate Sodium	59	14
Temazepam	Temazepam	58	suppressed
Pregabalin	Pregabalin	57	14
Farxiga	Dapagliflozin Propanediol	55	15
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	54	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	14
Duloxetine Hcl	Duloxetine Hcl	52	12
Famotidine	Famotidine	52	14
Trulicity	Dulaglutide	52	suppressed
Naproxen	Naproxen	51	14
Levofloxacin	Levofloxacin	49	33
Pravastatin Sodium	Pravastatin Sodium	49	11
Escitalopram Oxalate	Escitalopram Oxalate	48	suppressed
Testosterone Cypionate	Testosterone Cypionate	47	suppressed
Allopurinol	Allopurinol	45	13
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	13
Simvastatin	Simvastatin	44	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	25
Clopidogrel	Clopidogrel Bisulfate	43	17
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Nifedipine Er	Nifedipine	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	41	17
Methocarbamol	Methocarbamol	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Topiramate	Topiramate	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Nebivolol Hcl	Nebivolol Hcl	38	suppressed
Dexlansoprazole Dr	Dexlansoprazole	37	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	36	12
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Cephalexin	Cephalexin	34	23
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	34	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	20
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Colchicine	Colchicine	31	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	26	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Atenolol	Atenolol	23	suppressed
Benztropine Mesylate	Benztropine Mesylate	23	suppressed
Diclofenac Potassium	Diclofenac Potassium	23	suppressed
Hydrocortisone	Hydrocortisone	23	14
Finasteride	Finasteride	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Fluconazole	Fluconazole	21	12
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Betaxolol Hcl	Betaxolol Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Azithromycin	Azithromycin	18	11
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Humulin R	Insulin Regular, Human	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Mupirocin	Mupirocin	17	12
Baclofen	Baclofen	16	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Piroxicam	Piroxicam	16	suppressed
Diazepam	Diazepam	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Digoxin	Digoxin	11	suppressed
Glipizide	Glipizide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error